PIAS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.873370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.995800E-01
Normal-vs-Stage2
1.377430E-01
Normal-vs-Stage3
3.779800E-02
Normal-vs-Stage4
3.873200E-01
Stage1-vs-Stage2
2.403400E-01
Stage1-vs-Stage3
1.289650E-01
Stage1-vs-Stage4
6.843800E-01
Stage2-vs-Stage3
3.375400E-01
Stage2-vs-Stage4
6.778800E-01
Stage3-vs-Stage4
2.719600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.920020E-01
Normal-vs-AfricanAmerican
5.051200E-01
Normal-vs-Asian
2.939600E-02
Caucasian-vs-AfricanAmerican
4.470800E-01
Caucasian-vs-Asian
1.097760E-01
AfricanAmerican-vs-Asian
8.137600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.536950E-01
Normal-vs-Female
2.528800E-01
Male-vs-Female
3.191200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.817400E-01
Normal-vs-Age(41-60Yrs)
5.162400E-01
Normal-vs-Age(61-80Yrs)
8.417700E-02
Normal-vs-Age(81-100Yrs)
6.053800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.622600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.552000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.851200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.568130E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.010370E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.630600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.101100E-03
Normal-vs-Daily Drinker
1.276220E-01
Normal-vs-Weekly Drinker
2.342400E-01
Normal-vs-Occasional Drinker
3.325600E-01
Normal-vs-Social Drinker
7.738600E-01
Non Drinker-vs-Daily Drinker
5.891000E-01
Non Drinker-vs-Weekly Drinker
1.810370E-01
Non Drinker-vs-Occasional Drinker
2.882300E-02
Non Drinker-vs-Social Drinker
2.792400E-02
Daily Drinker-vs-Weekly Drinker
4.663600E-01
Daily Drinker-vs-Occasional Drinker
1.802160E-01
Daily Drinker-vs-Social Drinker
6.532000E-02
Weekly Drinker-vs-Occasional Drinker
6.059600E-01
Weekly Drinker-vs-Social Drinker
2.700400E-01
Occasional Drinker-vs-Social Drinker
4.277200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.301800E-01
Normal-vs-Grade 2
9.748200E-01
Normal-vs-Grade 3
9.276200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.782200E-01
Grade 1-vs-Grade 3
1.295240E-01
Grade 1-vs-Grade 4
8.301800E-01
Grade 2-vs-Grade 3
3.743800E-01
Grade 2-vs-Grade 4
9.748200E-01
Grade 3-vs-Grade 4
9.276200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.545700E-02
Normal-vs-NonDiabetic
1.657170E-01
Diabetic-vs-NonDiabetic
5.809600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.936000E-03
Normal-vs-NoPancreatitis
1.206440E-01
Pancreatitis-vs-NoPancreatitis
2.725400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.967600E-01
Normal-vs-N1
1.450960E-01
N0-vs-N1
7.002600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.033600E-02
Normal-vs-TP53-NonMutant
5.950200E-01
TP53-Mutant-vs-TP53-NonMutant
1.178450E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
